Hatef Darabi

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. pmc A meta-analysis of genome-wide association studies of follicular lymphoma
    Christine F Skibola
    School of Public Health, Division of Environmental Health Sciences, University of California, Berkeley, 94720, USA
    BMC Genomics 13:516. 2012
  2. pmc Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P, O, Box 281, Stockholm 177 71, Sweden
    Breast Cancer Res 14:R25. 2012
  3. pmc Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
    Yuqing Li
    Human Genetics, Genome Institute of Singapore, 60 Biopolis Street, Singapore 138672, Singapore
    Breast Cancer Res 13:R10. 2011
  4. pmc ESR1 and EGF genetic variation in relation to breast cancer risk and survival
    Kristjana Einarsdóttir
    Centre for Health Services Research, School of Population Health, University of Western Australia, 6009 Crawley, Perth, Western Australia
    Breast Cancer Res 10:R15. 2008
  5. doi request reprint Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res Treat 127:503-9. 2011
  6. doi request reprint Single- and multi-locus association tests incorporating phenotype heterogeneity
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Hum Hered 71:11-22. 2011
  7. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
  8. pmc GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
    Karin E Smedby
    Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
    PLoS Genet 7:e1001378. 2011

Collaborators

Detail Information

Publications8

  1. pmc A meta-analysis of genome-wide association studies of follicular lymphoma
    Christine F Skibola
    School of Public Health, Division of Environmental Health Sciences, University of California, Berkeley, 94720, USA
    BMC Genomics 13:516. 2012
    ....
  2. pmc Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P, O, Box 281, Stockholm 177 71, Sweden
    Breast Cancer Res 14:R25. 2012
    ..Over the last decade several breast cancer risk alleles have been identified which has led to an increased interest in individualised risk prediction for clinical purposes...
  3. pmc Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
    Yuqing Li
    Human Genetics, Genome Institute of Singapore, 60 Biopolis Street, Singapore 138672, Singapore
    Breast Cancer Res 13:R10. 2011
    ....
  4. pmc ESR1 and EGF genetic variation in relation to breast cancer risk and survival
    Kristjana Einarsdóttir
    Centre for Health Services Research, School of Population Health, University of Western Australia, 6009 Crawley, Perth, Western Australia
    Breast Cancer Res 10:R15. 2008
    ..We sought to determine if common genetic variation in the ESR1 and EGF genes affects breast cancer risk, tumour characteristics or breast cancer survival...
  5. doi request reprint Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res Treat 127:503-9. 2011
    ..008 and 0.011; 1-sided, respectively). Our results provide new evidence that CYP19A1 is involved in both breast cancer risk and prognosis...
  6. doi request reprint Single- and multi-locus association tests incorporating phenotype heterogeneity
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Hum Hered 71:11-22. 2011
    ....
  7. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
    ..ER status of breast cancer is important clinically, and is used both as a prognostic indicator and treatment predictor. In this study, we focused on identifying genetic markers associated with ER-negative breast cancer risk...
  8. pmc GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
    Karin E Smedby
    Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
    PLoS Genet 7:e1001378. 2011
    ..These findings suggest that the HLA class II region plays a complex yet important role in NHL...